STOCK TITAN

PHIBRO ANIMAL HEALTH CORP (PAHC) SEC Filings, Jul-Aug 2026

PAHC NASDAQ
Rhea-AI Summary

Phibro Animal Health’s Chief Financial Officer David Glenn reported an other disposition of 840 shares of Class A Common Stock on 2026-08-04 at an average price of $36.599 per share. These shares were sold in a broker-assisted cashless exercise to satisfy tax withholding upon vesting of restricted stock units, leaving him with 51,477 shares directly owned.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Daniel M Bendheim, President and CEO of Phibro Animal Health, reported the sale of 486 shares of Class A Common Stock at $36.599 per share on 2026-08-04. The disclosure states that these shares were sold in a broker-assisted cashless transaction to satisfy tax withholding upon the receipt of shares from vesting of restricted stock units, leaving him with 3,478 shares held directly afterward.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Phibro Animal Health Corp has a significant shareholder position reported by FMR LLC and Abigail P. Johnson in an amended ownership filing. FMR LLC reports beneficial ownership of 3,160,280.92 shares of Class A common stock of Phibro Animal Health Corp, representing 15.0% of that class as of June 30, 2026. FMR LLC has sole voting power over 3,159,853 shares and sole dispositive power over 3,160,280.92 shares, with no shared voting or dispositive power. Abigail P. Johnson is reported as having sole dispositive power over the same 3,160,280.92 shares and a 15.0% beneficial ownership stake, with no voting power. The filing notes that one or more other persons may have rights to receive dividends or sale proceeds from these shares, but no such person holds more than 5% of the outstanding Class A common stock.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
ownership
Filing
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
other
-
Filing
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
other
-
Filing
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
other
Filing
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
other
-
Filing
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
other
-
Filing
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
other
Rhea-AI Summary

Millennium Management LLC, Millennium Group Management LLC and Israel A. Englander report beneficial ownership of 1,064,608 shares of Phibro Animal Health Corporation Class A common stock, representing 5.1% of the class. They report shared voting and dispositive power over all these shares and no sole voting or dispositive power. The shares are held by entities over which Millennium Management LLC and related managers have voting control and investment discretion, with Mr. Englander serving as sole voting trustee of the managing member of Millennium Group Management LLC, while expressly not admitting beneficial ownership beyond what is required for this report.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
ownership

FAQ

How many PHIBRO ANIMAL HEALTH (PAHC) SEC filings are available on StockTitan?

StockTitan tracks 105 SEC filings for PHIBRO ANIMAL HEALTH (PAHC), including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, and Form 4 insider trading disclosures. Each filing includes AI-generated summaries, impact scoring, and sentiment analysis.

When was the most recent SEC filing for PHIBRO ANIMAL HEALTH (PAHC)?

The most recent SEC filing for PHIBRO ANIMAL HEALTH (PAHC) was filed on August 7, 2026.